James Benjamin Newman

James Newman practices at NYU Langone - Tisch Hospital in New York, New York.

James Newman's NPI, 1134582927, was assigned on March 30, 2016. James Newman graduated from SUNY Upstate Medical University in 2016. James Newman holds Connecticut license 1.079782.

James Newman's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-3130.

James Newman's primary practice is NYU Langone - Tisch Hospital in New York, New York. James Newman is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links James Newman to 3 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where James Newman practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is James Newman's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has James Newman's licenses on file in 2 states: Connecticut and New York.

CMS data shows 851 Medicare services from James Newman across 11 procedure codes in 2024, for 270 Medicare patients. Medicare paid $61,689 for them.

CMS counts 270 Medicare patients who saw James Newman in 2024. The largest group is 75 to 84, with 117 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts James Newman's median patient age at 70, with 61% women.

In 2024, James Newman wrote 164 Medicare Part D claims for 43 patients. 71% of them were for generic drugs. CMS names the drug for 44 of them, across 3 drugs with 11 or more claims each, at $12,512 in total drug cost. In 2023, CMS named 34 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for James Newman for performance year 2024, reported as part of a group. James Newman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists James Newman as offering telehealth.

CMS Open Payments shows 2 general payments to James Newman from 2 drug and device companies in 2022. Education make up the largest share, 95% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $80.

James Newman graduated from SUNY Upstate Medical University in 2016.